JoVE Logo
Faculty Resource Center

Sign In

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

DOI :

10.3791/55273-v

April 5th, 2017

April 5th, 2017

8,339 Views

1Department of Medicine, University of British Columbia

We have developed a modular high-throughput screening system for discovering novel compounds against Mycobacterium tuberculosis, targeting intracellular and in-broth growing bacteria as well as cytotoxicity against the mammalian host cell.

-- Views

Related Videos

article

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

article

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

article

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

article

A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes

article

piggyBac Transposon System Modification of Primary Human T Cells

article

Single Cell Measurements of Vacuolar Rupture Caused by Intracellular Pathogens

article

VIGS-Mediated Forward Genetics Screening for Identification of Genes Involved in Nonhost Resistance

article

Discovery of New Intracellular Pathogens by Amoebal Coculture and Amoebal Enrichment Approaches

article

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

article

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved